XML 19 R26.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2019
Schedule of weighted-average assumptions estimated at the date of grant using the Black-Scholes option pricing model

 

 

 

 

 

 

 

 

 

 

 

 

 

    

2019

    

    

2018

    

 

Expected stock price volatility

 

104.7

-

118.87

%  

 

106.64

-

113.19

%  

 

Expected term of options

 

5.16

-

6.1

years

 

5.2

-

6.1

years

 

Risk‑free interest rate

 

1.51

-

2.59

%  

 

2.32

-

3.1

%  

 

Expected annual dividend yield

 

 

 

0

%  

 

 

 

0

%  

 

 

Schedule of unrecognized compensation expense expected to be recognized in future years

That expense is expected to be recognized over the next four years as follows, in thousands:

 

 

 

 

 

2020

    

$

3,981

2021

 

 

2,941

2022

 

 

1,065

2023

 

 

304

 

 

$

8,291

 

Stock options  
Schedule of total compensation cost recognized in the statement of operations

 

Total compensation cost recognized for all stock option awards in the statements of operations is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2019

 

2018

 

Research and development

    

$

2,563

    

$

1,712

    

General and administrative

 

 

3,070

 

 

2,995

 

Total

 

$

5,633

 

$

4,707

 

 

Summary of activity for all options

A summary of activity for the years ended December 31, 2019 and 2018 is presented below (in thousand, except share and per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

Weighted‑

    

 

 

 

 

 

 

 

Average

 

Aggregate

 

 

 

 

 

Exercise Price

 

Intrinsic

 

 

 

Shares

 

Per Share

 

Value

 

Outstanding—December 31, 2017

 

3,754,320

 

$

5.22

 

 

 

 

Granted

 

1,372,000

 

 

6.60

 

 

 

 

Exercised

 

(12,308)

 

 

1.18

 

 

 

 

Forfeited

 

(162,603)

 

 

5.00

 

 

 

 

Outstanding—December 31, 2018

 

4,951,409

 

 

5.62

 

 

 

 

Granted

 

4,703,000

 

 

2.31

 

 

 

 

Exercised

 

(80,020)

 

 

1.22

 

 

 

 

Forfeited

 

(916,205)

 

 

4.21

 

 

 

 

Expired

 

(117,903)

 

 

8.23

 

 

 

 

Outstanding—December 31, 2019

 

8,540,281

 

$

3.95

 

$

3,774

 

 

 

 

 

 

 

 

 

 

 

Exercisable—December 31, 2019

 

4,431,560

 

$

5.04

 

$

1,447

 

Exercisable and expected to vest—December 31, 2019

 

8,540,281

 

$

3.95

 

$

3,774

 

 

Restricted stock  
Schedule of total compensation cost recognized in the statement of operations

Total compensation cost recognized for all restricted stock awards in the statements of operations for the years ended December 31, 2019 and 2018 is as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

 

December 31,

 

 

 

2019

 

2018

 

Research and development

    

$

19

    

$

19

    

General and administrative

 

 

20

 

 

62

 

Total

 

$

39

 

$

81

 

 

Summary of activity for all restricted stock

A summary of activity for the years ended December 31, 2019 and 2018 is presented below:

 

 

 

 

 

 

 

 

    

 

    

Weighted‑average

 

 

 

 

Grant Date

 

 

Shares

 

Fair Value per Share

Outstanding—December 31, 2017

 

239,800

 

$

1.21

Vested

 

(120,600)

 

 

1.21

Forfeited

 

(14,000)

 

 

1.21

Outstanding—December 31, 2018

 

105,200

 

 

1.21

Vested

 

(52,600)

 

 

1.21

Forfeited

 

(20,200)

 

 

1.21

Outstanding—December 31, 2019

 

32,400

 

$

1.21

 

 

 

 

 

 

Expected to vest—December 31, 2019

 

32,400

 

$

1.21